Indication
Thrombosis in heparin-induced thrombocytopenia
Thrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin. Read more about Thrombosis in heparin-induced thrombocytopenia
28 drugs 23 manufacturers
Drugs that treat it
Common Thrombosis in heparin-induced thrombocytopenia therapies.
ARGATROBAN-0.9% NACL (argatroban in 0.9 % sodium chloride)
ARGATROBAN
ARGATROBAN-SODIUM CHLORIDE (argatroban in sodium chloride, iso-osmotic)
ARGATROBAN
ARGATROBAN-SODIUM CHLORIDE (argatroban in sodium chloride, iso-osmotic)
ARGATROBAN-SODIUM CHLORIDE (argatroban in sodium chloride, iso-osmotic)
ARGATROBAN
ARGATROBAN-0.9% NACL (argatroban in 0.9 % sodium chloride)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin.
This disorder arises when IgG autoantibodies form against complexes of platelet factor 4 and heparin, which bind platelet Fc?RIIa receptors to trigger extensive platelet activation, aggregation, and substantial thrombin generation.
Primarily affecting the vascular and hematologic systems, it leads to a typical drop in platelet counts alongside high risks of new or progressive venous and arterial thromboembolic events, such as deep vein thrombosis, pulmonary embolism, stroke, limb ischemia, or acute myocardial infarction.
- nih.gov
Thrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin Primarily affecting the vascular and hematologic systems, it leads to a typical drop in platelet counts alongside high risks of new or progressive venous and arterial thromboembolic events, such as deep vein thrombosis, pulmonary embolism, ...
- openanesthesia.org
Thrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin
- mdedge.com
Thrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin
- nih.gov
This disorder arises when IgG autoantibodies form against complexes of platelet factor 4 and heparin, which bind platelet FcγRIIa receptors to trigger extensive platelet activation, aggregation, and substantial thrombin generation
- nih.gov
This disorder arises when IgG autoantibodies form against complexes of platelet factor 4 and heparin, which bind platelet FcγRIIa receptors to trigger extensive platelet activation, aggregation, and substantial thrombin generation Primarily affecting the vascular and hematologic systems, it leads to a typical drop in platelet counts alongside high risks of new or progressive venous and arterial thromboembolic events, such as deep vein thrombosis, pulmonary embolism, stroke, limb ischemia, or acu...
- clevelandclinic.org
Primarily affecting the vascular and hematologic systems, it leads to a typical drop in platelet counts alongside high risks of new or progressive venous and arterial thromboembolic events, such as deep vein thrombosis, pulmonary embolism, stroke, limb ischemia, or acute myocardial infarction
Personalize your experience
Follow Thrombosis in heparin-induced thrombocytopenia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.